The levels of CXCL13 and IL-21 expressed by tumor-infiltrating Tfh cells in patients who received neoadjuvant chemotherapy was higher than those in patients who had not (Figure 6B), although the proportion of Tfh cells showed no obvious difference (Figure 6A). This evidence concerns the gene IL21 and neoplasm.